Type 2 Diabetes Trial, Recruiting NCT06028503 Sponsor: Sam Houston State University Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT06028503
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with diabetes (based on self-reporting) and have a blood sugar level (HbA1c) of 6.0 or higher, measured by a quick test at the visit
  • People who are 18 years of age or older
  • People who are able to speak English
  • People who are able to understand the study and agree to take part
  • People who have reliable access to their own smartphone
  • People who live in a rural area (based on their zip code)

Who may not be able to join:

  • People who report thoughts of suicide at their first visit
  • People who show signs of a serious mental health crisis that would prevent them from giving informed consent
  • People who have significant cognitive difficulties that would prevent them from giving informed consent
  • People who use large amounts of alcohol or other substances
  • People whose overall health situation is considered too complicated for the type of treatment being studied, as determined by the study team
  • People who have a pacemaker or any other electrical medical device implanted in their body
  • People who are pregnant, as managing diabetes during pregnancy may need extra medical supervision
  • People under 18 years old
  • People who do not speak English, as the study process has not been translated or tested in other languages

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (936)294-3614

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sam Houston State University
Registry
ClinicalTrials.gov
Start date
1 April 2024
Est. completion
31 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Reduction in Hemoglobin A1C

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov